Cover Image

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice

Fenofibrate is widely used in clinical therapy to effectively ameliorate the development of non-alcoholic fatty liver disease (NAFLD); however, its specific molecular mechanism of action remains largely unknown. MicroRNAs (miRNAs) are key mediators in regulating endoplasmic reticulum (ER) stress dur...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Zhang (Author), Shanzhuang Niu (Author), Yicheng Ma (Author), Hang Chen (Author), Yu Wen (Author), Mingke Li (Author), Bo Zhou (Author), Yi Deng (Author), Chunjing Shi (Author), Guangyu Pu (Author), Meng Yang (Author), Xianmei Wang (Author), Chenggang Zou (Author), Yuanli Chen (Author), Lanqing Ma (Author)
Format: Book
Published: Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items